Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis. - Wikidata - awgldk - TriplyDB

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

http://www.wikidata.org/entity/Q45711137

about

WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling.BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications.Molecular pathology in real time.MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.Mutations of key driver genes in colorectal cancer progression and metastasis.[Molecular pathology of colorectal cancer].Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry

P2860

Q33917543-71DE8101-167E-4826-9B42-CA20BD5AC7A8 Q35962621-91B0BDDC-8AB7-4BBD-B165-624FDD5D78AC Q36074183-0791CBCA-6359-4654-898B-0D826F501D53 Q36814884-510FED26-55D5-4039-8954-34359A214F3F Q37525272-E746090A-0457-4967-B895-E12D07ADB8FC Q37578728-B3AA1A7D-4357-484D-9D6A-73013C66D1DF Q38722180-AB846AF9-8384-4E58-98CF-B523A4A27628 Q38756841-D7BD7576-E294-4B69-8B99-D7D8E4FBB708 Q39390383-80E4C8F7-8C74-4CF8-95BA-F15CE32C213F Q41473710-5AA3A14F-22BB-46E0-AF08-ACBE3AA75B8B Q42372850-AE5FF867-6F1B-4F39-8828-EE562BC9DFA8 Q49569642-5B9DE64C-FB75-4E6A-97FE-14C469A656CE Q50097873-F0183139-4AF3-4683-BC9A-41AA83AEE508 Q53581884-FA1421B5-FE20-4E87-85B2-8BC09881F042 Q54334205-096C20E6-EAAB-49C8-AC82-FFF4675DA3A0 Q54393310-51FEB63A-55E2-4D58-9924-59CC5E19B9AB Q57567361-13D9EBFC-9CF7-4348-BCE6-60FFB74CE99B

P2860

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

http://www.wikidata.org/entity/Q45711137

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@en

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@nl

type

label

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@en

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@nl

prefLabel

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@en

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@nl

P1433

Q45711137-CC087632-F537-4D96-9F33-DDF3F271804A

P1476

Q45711137-2294F2D8-EED3-46D6-987F-279686D83C93

P2093

Q45711137-3E2D526C-95F1-48D5-85E0-FAC55BD6FD2C

Q45711137-7C9EB22C-2FD0-4357-90B3-698C3805E888

Q45711137-8B82EE06-6745-4520-BA4B-5EB9EB3333A9

Q45711137-D7C459D9-77C8-42D2-B79E-1AC545810633

Q45711137-DC777BF2-9623-49A4-B4DF-91245F983803

Q45711137-E160DF77-85C3-4017-BA7B-845B4515A996

P2860

Q45711137-08708AFB-9F5D-48E5-BE96-014C70D9043F

Q45711137-08AAD70A-B93E-4E81-A1A2-EFFDC02E2F24

Q45711137-0AE6A577-02FD-4757-8715-0AF16321E150

Q45711137-165571AD-388E-4F80-A9BD-E5DBC024B8C1

Q45711137-1C632716-0A31-400E-BFB1-88D5F0CDE88B

Q45711137-236834F8-6685-4D0C-8FA6-CD76E2877671

Q45711137-2A17FB0F-EECA-44CF-8F3A-48A9C3E0142E

Q45711137-3E6CA35D-F30D-423C-AD38-91492DC9A74B

Q45711137-3F50F063-437F-46A3-9955-89DA42727733

Q45711137-4CB5835A-3F81-48C0-99C6-375D74F78F1E

P2888

Q45711137-9B36EABA-D65F-4921-A8E4-238117E39EA4

P304

Q45711137-DC47280C-B966-4132-8D84-E4F9F556D943

P31

Q45711137-1EEE773C-8431-48F4-B209-1FA214C4E841

P356

Q45711137-6FF96622-9B5F-4F6C-813C-691CEEFB55AF

P433

Q45711137-A584164A-85F2-4C99-8BAA-AE2094187C46

P478

Q45711137-B493099A-E124-48D1-862E-1826F7C6909C

P577

Q45711137-D5EC60EA-F27E-474F-AD1C-6B7B6C6C1F6B

P6179

Q45711137-427DD684-9717-43B9-81F1-98006E221ACD

P698

Q45711137-9CDA7647-A8EC-4884-A54C-4D37D3BC9A82

P921

Q45711137-2B518828-1BF4-4F44-9B4C-5FB1C3B1A4C4

P356

S00428-013-1450-0

P1433

Virchows Archiv

P1476

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

@en

P2093

Andreas Jung

http://www.w3.org/2001/XMLSchema#string

Jens Neumann

http://www.w3.org/2001/XMLSchema#string

Jutta Engel

http://www.w3.org/2001/XMLSchema#string

Laura Wehweck

http://www.w3.org/2001/XMLSchema#string

Susanne Maatz

http://www.w3.org/2001/XMLSchema#string

Thomas Kirchner

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

HER2 testing in gastric cancer: a practical approach

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis

Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas.

KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer

EGFR Signaling in Colorectal Carcinoma.

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

P2888

s00428-013-1450-0

P304

509-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-013-1450-0

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

463

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042809798

http://www.w3.org/2001/XMLSchema#string

P698

23934607

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer